A study of Li+-selective permeation through lipid bilayer membranes mediated by a new ionophore (AS701)

The neutral, noncyclic, imide and ether containing ionophore AS701, has been developed as Li⁺-selective molecule, to be used potentially as an aid in the Li⁺-therapy of manic-depressive illness. The present report is a characterization of this molecule in neutral lipid bilayer membranes. This ionophore was found to the bilayers Li⁺-selective, acting as a selective carrier of monovalent cations. In addition, this molecule was found to be capable of acting as a selective carrier of monovalent anions. For both types of ions, the rate-limitting step in the process of permeation was found to be the diffusion of the carrier-ion complex through the membrane. The membrane-permeating species were found to be 2 : 1 carrier-ion complexes, carrying either a monovalent cation or a monovalent anion. The selectivity sequences among the ions studied being: Li⁺(1) > ClO₄^?(0.7) > Na⁺(0.07) > K⁺(0.016) > Rb⁺(0.0095) > Cs⁺(0.0083) > Cl^?(0.001). Mg²⁺ and SO₄^2? were found to be impermeant (under present experimental conditions). This sequence shows that the AS701 molecule has low selectivity for ions present in biological media, among those studied (i.e. Na⁺, K⁺, Mg²⁺, Cl^2? and SO₄^2?). This indicates that these ions will not interfere in the Li⁺ permeability induced by this carrier in vivo, and that the carrier will not interfere in the normal transport processes of these ions.